Organic light-emitting device, apparatus including the same, and organometallic compound

US12289985B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12289985-B2
Application numberUS-201916446130-A
CountryUS
Kind codeB2
Filing dateJun 19, 2019
Priority dateSep 21, 2018
Publication dateApr 29, 2025
Grant dateApr 29, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are an organic light-emitting device, an apparatus including the organic light-emitting device, and an organometallic compound represented by Formula 1. The organic light-emitting device includes: a first electrode; a second electrode; and an organic layer between the first electrode and the second electrode and including an emission layer, wherein: the organic layer includes the organometallic compound represented by Formula 1.

First claim

Opening claim text (preview).

What is claimed is: 1. An organic light-emitting device comprising: a first electrode; a second electrode; and an organic layer between the first electrode and the second electrode and comprising an emission layer, wherein: the organic layer comprises an organometallic compound represented by Formula 1: wherein, in Formulae 1, 1-1, 2-1, 2-26, 3-1, and 3-2, M 1 is selected from a Period 1 transition metal, a Period 2 transition metal, and a Period 3 transition metal; *1 to *4 each indicate a binding site to M 1 ; L 1 is a ligand represented by Formula 1-1; L 2 is selected from a monodentate ligand and a bidentate ligand; n1 is 1, n2 is selected from 0, 1, and 2; A 11 to A 14 are each independently selected from a group represented by Formula 2-1, a group represented by Formula 2-26, a group represented by Formula 3-1, a group represented by Formula 3-2, a C 5 -C 60 carbocyclic group, and a C 1 -C 60 heterocyclic group; at least one selected from A 11 to A 14 is selected from a group represented by Formula 2-1 and a group represented by Formula 2-26; and at least one selected from A 11 to A 14 is selected from a group represented by Formula 3-1 and a group represented by Formula 3-2; Y 11 to Y 14 are each independently selected from N and C; T 11 to T 14 are each independently selected from a single bond, *—O—* ‘, and *—S—*’; L 11 to L 14 are each independently selected from a single bond, *—O—*′, *—S—*′, *—C(R 17 )(R 18 )—*′, *—C(R 17 )═*′, *═C(R 17 )—*′, *—C(R 17 )═C(R 18 )—*′, *—C(═O)—*′, *—C(═S)—*′, *—C═C—*′, *—B(R 17 )—*′, *—N(R 17 )—*′, *—P(R 17 )—*′, *—Si(R 17 )(R 18 )—*′, *—P(R 17 )(R 18 )—*′, and *—Ge(R 17 )(R 18 )—**; a11 to a14 are each independently selected from 0, 1, 2, and 3, and at least three selected from a11 to a14 are selected from 1, 2, and 3; when a11 is 0, A 11 and A 12 are not linked to each other, when a12 is 0, A 12 and A 13 are not linked to each other, when a13 is 0, A 13 and A 14 are not linked to each other, and when a14 is 0, A 14 and A 11 are not linked to each other, R 11 to R 14 , R 17 , and R 18 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 ) (Q 3 ), —B(Q 1 )(Q 2 ), —N(Q 1 )(Q 2 ), —P(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O)(Q 1 ), —S(═O) 2 (Q 1 ), —P(═O)(Q 1 )(Q 2 ), and —P(═S)(Q 1 )(Q 2 ); R 17 and R 11 , R 17 and R 12 , R 17 and R 13 , and/or R 17 and R 14 are optionally linked to each other to form a substituted or unsubstituted C 5 -C 60 carbocyclic group or a substituted or unsubstituted C 1 -C 60 heterocyclic group, R 17 and R 18 are optionally linked to each other to form a substituted or unsubstituted C 5 -C 60 carbocyclic group or a substituted or unsubstituted C 1 -C 60 heterocyclic group, b11 to b14 are each independently selected from 1, 2, 3, 4, 5, 6, 7, and 8; X 21 is selected from O, S, N(R 24 ), and C(R 24 )(R 25 ); X 22 to X 25 are each independently selected from N and C, X 26a is N, N—*, or C(R 26a ), X 26b is N, N—*, or C(R 26b ), X 26c is N, N—*, or C(R 26c ), X 26d is N, N—*, or C(R 26d ), X 26e is N, N—*, or C(R 26e ), X 26f is N, N—*, or C(R 26f ), X 26g is N, N—*, or C(R 26g ), X 26h is N, N—*, or C(R 26h ), A 21 and A 22 are each independently selected from a C 5 -C 60 carbocyclic group and a C 1 -C 60 heterocyclic group; X 31 is N, N—*, or C(R 31 ), X 32 is N, N—*, or C(R 32 ), X 33 is N, N—*, or C(R 33 ), X 34 is N, N—*, or C(R 34 ), X 35 is N, N—*, or C(R 35 ), X 36 is N, N—*, or C(R 36 ), X 37 is N, N—*, or C(R 37 ), and X 38 is N, N—*, or C(R 38 ), two or more selected from X 31 to X 34 are each independently N or N—*, one or more selected from X 35 to X 38 each independently N or N—*, A 31 is selected from a C 5 -C 60 carbocyclic group and a C 1 -C 60 heterocyclic group; A 32 is a C 1 -C 60 heterocyclic group containing at least one N, R 21 to R 25 , R 26a to R 26h , and R 31 to R 39 are each independently selected from a binding site, hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 ) (Q 3 ), —B(Q 1 )(Q 2 ), —N(Q 1 )(Q 2 ), —P(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O)(Q 1 ), —S(═O) 2 (Q 1 ), —P(═O)(Q 1 )(Q 2 ), and —P(═S)(Q 1 )(Q 2 ); one, two, or three selected from R 21 to R 25 are binding sites, one, two, or three selected from R 24 , R 25 and R 26a to R 26h in Formula 2-26 are binding sites, one, two, or three selected from R 31 to R 34 and R 39 are binding sites, one, two, or three selected from R 35 to R 39 are binding sites, Q 1 to Q 3 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a C 1 -C 60 heteroaryloxy group, a C 1 -C 60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group; provided that none of A 11 to

Assignees

Inventors

Classifications

  • Assemblies of multiple devices comprising at least one organic light-emitting element · CPC title

  • Cathodes · CPC title

  • Anodes · CPC title

  • Platinum compounds · CPC title

  • H10K85/346Primary

    comprising platinum · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12289985B2 cover?
Provided are an organic light-emitting device, an apparatus including the organic light-emitting device, and an organometallic compound represented by Formula 1. The organic light-emitting device includes: a first electrode; a second electrode; and an organic layer between the first electrode and the second electrode and including an emission layer, wherein: the organic layer includes the organ…
Who is the assignee on this patent?
Samsung Display Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07F15/0086. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).